[Nosocomial pneumonia]

Santiago Ewig1

  • 1Thoraxzentrum Ruhrgebiet, Kliniken für Pneumologie und Infektiologie, EVK Herne und Augusta-Krankenhaus Bochum, Hordeler Straße 7-9, 44651, Herne, Deutschland. s.ewig@evk-herne.de.

Die Anaesthesiologie
|August 13, 2024
PubMed

Insights

Nosocomial pneumonia, acquired ≥48 hours after hospital admission, requires prompt diagnosis and tailored antimicrobial therapy. Early re-evaluation and diagnostic work-up are crucial for managing treatment failures in these critical infections.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pulmonology

Background:

  • Nosocomial pneumonia (NP) is a significant hospital-acquired infection.
  • It affects both spontaneously breathing and ventilated patients.
  • Risk factors for multidrug-resistant pathogens (MDRP) influence initial treatment strategies.

Purpose of the Study:

  • To outline diagnostic and management guidelines for nosocomial pneumonia.
  • To emphasize the importance of microbiological cultures in guiding therapy.
  • To detail the approach to treatment failure in NP.

Main Methods:

  • Review of diagnostic criteria for NP.
  • Guidelines for microbiological sampling (tracheobronchial aspirates, bronchoalveolar lavage).
  • Principles of empirical and targeted antimicrobial therapy selection based on MDRP risk.

Main Results:

  • Initial antimicrobial treatment is guided by MDRP risk, with combination therapy favored when MDRP prevalence is high.
  • Microbiological results should guide adaptation of antibiotic treatment.
  • Mandatory standardized re-evaluation after 72 hours is essential.

Conclusions:

  • Effective management of nosocomial pneumonia hinges on timely diagnosis, appropriate microbiological investigation, and risk-stratified antimicrobial selection.
  • Treatment adaptation based on culture results and structured re-evaluation are key to improving outcomes.
  • Primary treatment failure necessitates a comprehensive diagnostic re-evaluation before further antibiotic administration.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
215
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
237
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.1K